| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |